Rankings
Pricing
Log In
Free Trial
US-listed companies
Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc.
RPHM
Market cap
$60.63M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2021
Dec 31,
2022
Net loss
-40
-52
Stock-based compensation
4
4
Depreciation and amortization
0
0
Amortization/accretion on short-term investments
-0
1
Changes in the fair value of performance award
0
-0
Non-cash lease expense
-
-0
Loss on disposal of fixed asset
-
-0
Prepaid expenses and other assets
5
-1
Accounts payable and accrued expenses
2
1
Operating lease liabilities
-
-0
Net cash used in operating activities
-38
-47
Purchase of property and equipment
0
0
Purchase of available-for-sale short-term investments
31
102
Proceeds from maturities of available-for-sale short-term investments
8
44
Net cash used in investing activities
-23
-58
Proceeds from Issuance of Convertible Preferred Stock
47
-
Proceeds from Issuance of Common Stock
85
0
Proceeds from issuance of common stock in connection with equity plans
-
0
Net cash provided by financing activities
132
0
Net (decrease) increase in cash and cash equivalents
71
-105
Right-of-use assets obtained in exchange for lease obligations
-
2
Vesting of unvested exercised options
0
-